Marc Wasserman is listed as a director on 1 SEC Form D filing by 1 issuer in Oct 2016: Cambridge Therapeutic Technologies, LLC (Teaneck, NJ — pharmaceuticals — 2016; $6M reported sold to 14 investors).
What this means One deal on file with the SEC, filed Oct 2016. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Barry A. Posner (1 shared filing), John Klein (1 shared filing) and Joseph DosSantos (1 shared filing).
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Marc. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, LA, ME, MO, MS, MT, NASAA, NC, NH, NM, OR, RI, TX, WA) — 2 court cases matching the name, 3 bankruptcy cases matching the name listed in Key records below.
What this means 5 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 1 public filing for Marc Wasserman and found 2 differences: No amendment in the last 12 months on an offering that may still be open; Same name, different state: "Marc Wasserman" (IL) is a separate record.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.